NAFLD (beta = 0.086 [0.041, 0.131], P = 1.56×10−4) was a risk factor for circulating AST, while hypertension did not affect either ALT or AST. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.